# Evaluation of the Simplified Treat And Extend Regimen Using Ranibizumab in Exudative Age Related Macular Degeneration

> **NCT02328209** · NA · UNKNOWN · sponsor: **Mie University** · enrollment: 50 (estimated)

## Conditions studied

- Exudative Age-related Macular Degeneration

## Interventions

- **DRUG:** ranibizumab

## Key facts

- **NCT ID:** NCT02328209
- **Lead sponsor:** Mie University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-06
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2014-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02328209

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02328209, "Evaluation of the Simplified Treat And Extend Regimen Using Ranibizumab in Exudative Age Related Macular Degeneration". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02328209. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*